Long-term health outcomes and quality of life in women with untreated pelvic floor dysfunction: a single-center cohort study

Abstract

Objective:

This study aimed to evaluate the long-term health outcomes and quality of life (HRQoL) associated with untreated pelvic floor dysfunction (PFD) in women, and to identify key factors contributing to symptom severity.

Methods:

A cohort of 1,651 women aged 18 years and older with untreated PFD were recruited between June 2018 and August 2023. Data on sociodemographic, lifestyle factors, and clinical history were collected via questionnaires and clinical assessments. The Pelvic Floor Distress Inventory (PFDI-20) and Short Form-12 (SF-12) were used to assess symptom severity and HRQoL.

Results:

The study found that 56% of participants experienced urinary incontinence (UI), 52% had pelvic organ prolapse (POP), and 47% reported gynecological disorders. Sleep apnea (OR: 18.3, p < 0.001) and menopause (OR: 2.48, p < 0.001) were significantly associated with higher symptom severity, while postpartum complications had a protective effect (OR: 0.01, p < 0.001). Obesity was inversely associated with symptom severity (OR: 0.3, p < 0.001). HRQoL scores showed that 97.6% of participants had high physical functioning (mean PF: 67.36 ± 11.62), but vitality (VT) was notably lower, with 27.8% scoring below 50 (mean VT: 54.84 ± 6.60). FI (p = 0.006) and pelvic pain (p = 0.001) were linked to significantly poorer physical functioning and higher bodily pain.

Conclusion:

Untreated PFD has a profound impact on HRQoL, especially in women with sleep apnea, menopause, and pelvic pain. Early diagnosis and intervention are critical to mitigating these effects and improving long-term outcomes. These findings highlight the urgent need for targeted public health strategies to address untreated PFD.

1 Introduction

Pelvic floor dysfunction (PFD) encompasses a range of conditions affecting the pelvic floor muscles and connective tissues, leading to compromised support of pelvic organs such as the bladder, uterus, and rectum (1, 2). Among the primary clinical manifestations are pelvic organ prolapse (POP), urinary incontinence (UI), fecal incontinence (FI), and chronic pelvic pain (CPP) (2, 3). Despite its high prevalence, especially among aging and postpartum women, PFD often remains undiagnosed and untreated. The long-term public health outcomes of untreated PFD have serious implications, particularly when considering its significant impact on the quality of life, psychological wellbeing, and healthcare burden (3, 4). Moreover, untreated PFD can lead to severe complications, including irreversible damage to pelvic organs, recurring infections, and chronic disability (4, 5).

In China, PFD is emerging as a critical public health issue due to an aging population and increasing life expectancy (6). China's rapid economic growth, combined with a declining birth rate and the aftereffects of the one-child policy, has created a demographic shift that emphasizes the healthcare needs of older women (7, 8). Studies estimate that by 2050, over 30% of China's population will be aged 60 or above, with a significant proportion of these individuals at risk for pelvic floor disorders (8, 9). Despite the growing incidence, awareness and treatment options for PFD remain limited, particularly in rural and underserved regions (10, 11). The social and cultural barriers to seeking treatment, coupled with a lack of trained healthcare professionals, further exacerbate this issue (11, 12).

The epidemiological burden and clinical sequelae of untreated PFD constitute a significant global health concern with substantial implications for female morbidity and HRQoL metrics (13). PFD manifests as a heterogeneous spectrum of clinical entities, encompassing UI, POP, FI, and pelvic-perineal pain syndromes, with varying degrees of symptom overlap and severity (13, 14). Contemporary epidemiological data demonstrate high prevalence rates across international populations, with marked diagnostic and therapeutic disparities observed in resource-limited settings, particularly throughout the Asia-Pacific region (14, 15).

Regional epidemiological analyses from Asia indicate a substantial disease burden, with cross-sectional studies documenting that ~35–45% of women experience at least one form of PFD (15). Specifically within Chinese populations, systematic reviews have reported prevalence rates of 25–40% for POP and 20–35% for UI, with associated significant decrements in validated quality of life measures (16, 17). The socioeconomic impact extends beyond individual health outcomes, manifesting in increased healthcare utilization patterns, elevated direct medical costs, and documented reductions in workforce productivity and labor force participation (17, 18).

Epidemiological data reveal distinct prevalence patterns across PFD subtypes, with UI affecting 55.8% of study participants, while FI, symptomatic uterine prolapse, and pelvic pain demonstrate rates of 10.4%, 14.0%, and 18.7%, respectively (19). These stratified prevalence data, coupled with projected demographic shifts and increasing life expectancy, underscore the imperative for evidence-based preventive interventions and standardized treatment algorithms to address the escalating burden of PFD on healthcare systems (20, 21).

In China, a study examining the knowledge, attitudes, and practices of women of childbearing age regarding PFD and pelvic floor ultrasound found that there was a significant gap in knowledge and awareness about these conditions (22). These identified knowledge gaps correlate with delayed healthcare-seeking behaviors and subsequent diagnostic delays, potentially exacerbating clinical outcomes in untreated PFD cohorts (23, 24). Despite documented high prevalence rates, longitudinal public health implications of PFD remain insufficiently characterized, particularly within rapidly aging demographic contexts such as China. Current epidemiological data demonstrate notable limitations regarding the temporal relationship between untreated PFD and its impact on HRQoL metrics and healthcare resource utilization patterns. Despite documented high prevalence rates, longitudinal implications of PFD remain incompletely characterized, particularly in rapidly aging populations. Through rigorous examination of these multifactorial relationships, this study aims to generate evidence-based insights to inform clinical intervention strategies, enhance early detection protocols, and guide public health policy development for at-risk populations. Our methodological approach emphasizes identification of modifiable risk factors and optimization of resource allocation for PFD management within contemporary healthcare systems.

2 Methodology

2.1 Study design and setting

This single-center, observational cohort study was conducted between June 2018 and August 2023 in China. The primary objective was to investigate the long-term health outcomes associated with untreated PFD in women. Eligible participants were women aged 18 years and older who presented with symptoms indicative of PFD, including UI, FI, POP, and pelvic pain. Exclusion criteria encompassed women who had received prior treatment for PFD, were pregnant, or had given birth within the previous 12 months. Additionally, women with cognitive impairments that could potentially interfere with accurate data collection were excluded.

To ensure sufficient statistical power for detecting significant associations between PFD and the public health outcomes of interest, a sample size of 1,651 women was recruited. This calculation was based on a 95% confidence level, a 3% margin of error, and a projected 25% prevalence of PFD in the population (19, 25). Anticipating a 10% dropout rate, recruitment efforts were conducted through healthcare centers, women's organizations, and online platforms. All participants provided informed consent prior to study enrollment.

2.2 Study population and sample size

Data collection occurred at baseline and during follow-up assessments at up to 12 months. Participants' sociodemographic characteristics, clinical history, and lifestyle factors were recorded using validated, pre-tested questionnaires administered by trained healthcare personnel. The primary variables of interest included:

• Sociodemographic data: age, body mass index (BMI), marital status (married, single, divorced, or widowed), employment sector (administration, industry, public service), and income level (categorized as higher, higher middle, lower middle, or middle income).

• Lifestyle factors: smoking habits (yes or no), frequency of alcohol consumption (daily, frequent, occasional, or never), physical activity levels (assessed through the International Physical Activity Questionnaire, IPAQ), and sleep quality (evaluated using the Pittsburgh Sleep Quality Index, PSQI).

• Obstetric and gynecological history: number of pregnancies, type of delivery (vaginal or instrumental), menopausal status, postpartum complications (perineal tears, pelvic floor trauma, uterine prolapse, and postpartum hemorrhage), and history of gynecological disorders (endometriosis, uterine fibroids, and ovarian cysts).

• PFD: the Pelvic Floor Distress Inventory (PFDI-20) was employed to evaluate the severity of PFD symptoms across three domains: POP (POPDI-6), colorectal-anal symptoms (CRADI-8), and urinary symptoms (UDI-6).

2.3 Clinical assessments

Physical examination employed standardized protocols encompassing POP-Q staging, Q-tip testing for urethral mobility, cough stress testing, and dynamic Valsalva maneuvers. All assessments adhered to validated clinical guidelines ensuring diagnostic consistency and reproducibility through examiner standardization protocols.

2.4 Quality of life measurement

HRQoL was assessed using the Short Form-12 (SF-12) questionnaire (26), measuring both physical health (physical functioning, role physical, bodily pain, general health) and mental health (vitality, social functioning, role emotional, mental health) on a 0-100 scale, with higher scores indicating better health status. Study instruments also included the Pelvic Floor Distress Inventory (PFDI-20) (27) and Pittsburgh Sleep Quality Index (PSQI) (28). In addition, CPP was assessed using the Visual Analog Scale (VAS), a validated instrument widely utilized in clinical research for quantifying pain intensity. Scores ranged from 0 (no pain) to 10 (worst possible pain), with participants marking their perceived pain severity along a 10 cm line. The use of VAS in this study ensured standardization and reproducibility in assessing pain intensity, which is crucial for comparing outcomes across similar clinical studies.

2.5 Outcome measures

The primary measures were:

• Prevalence of PFD: defined based on self-reported symptoms corroborated by clinical assessments, including UI, FI, POP, and pelvic pain.

• Impact on quality of life: assessed using SF-12 scores, measuring both physical and mental health dimensions.

• Long-term complications: included the recurrence of PFD symptoms, development of new symptoms, and other associated morbidities over time.

• Healthcare utilization: monitored through the frequency of medical consultations, hospitalizations, and any surgical interventions related to PFD throughout the study period.

2.6 Statistical analysis

The data for this study were analyzed using a combination of descriptive and inferential statistical methods. Continuous variables, such as age and body mass index (BMI), were summarized as means with standard deviations, while categorical variables, including civil status and employment sector, were presented as frequencies and percentages. For the univariate analysis, independent t-tests were employed to assess associations between continuous variables and PFD, while chi-square tests were applied to categorical variables. Key outcomes, such as the severity of PFD symptoms measured by the Pelvic Floor Distress Inventory (PFDI-20) subscales—POPDI-6, CRADI-8, and UDI-6—and quality of life scores from the SF-12 questionnaire, were evaluated by calculating mean differences (MD) with 95% confidence intervals (CIs).

Multivariate binary regression models controlled confounding factors in examining relationships between sociodemographic, lifestyle, and clinical variables with PFD outcomes, providing adjusted mean differences (MDs) and 95% confidence intervals (CIs). Models incorporated interaction terms for age, BMI, and menopause status. Longitudinal changes were assessed using repeated measures ANOVA, with Friedman tests employed for non-normally distributed data. Model interaction effects were tested through regression analyses to examine how factors like age and menopause modify PFD-outcome relationships (p < 0.05). Sensitivity analyses assessed result robustness, examining missing data patterns and parametric test assumptions. When distributional assumptions were violated, bootstrapping generated reliable standard error and confidence interval estimates, enabling precise characterization of PFD progression determinants.

3 Results

The study included 1,651 women with a mean age of 45 years (±15) and an average BMI of 25.0 (±4.7). Most participants were married (68%), while 23% were single. In terms of employment, self-employed women made up the largest group (16%), followed by those in administration (15%) and public service (15%). Higher middle-income (36%) was the most common income category. Non-smokers accounted for 87%, and 54% reported occasional alcohol consumption. Regarding health, sexual dysfunction affected 47% of women, sleep apnea was prevalent in 54%, and 65% reported postpartum complications. Menopause occurred in 29%, and 80% had two or more vaginal births. Obesity was present in 49%, while 47% had gynecological disorders and 37% had experienced urinary tract infections. FI was observed in 11% of participants, while 36% reported CPP, highlighting the significant burden of these conditions. Cardiovascular illnesses affected 42%, and 36% reported obstetric complications. UI was noted in 56%, and POP in 52%. HRQoL scores showed mean values of 67 (±12) for physical functioning, 60 (±10) for role physical, and 63 (±10) for bodily pain. Mental health had a mean score of 66 (±13). The physical component summary had a mean of 68.8 (±4.1), and the mental component summary was 65.17 (±2.74), reflecting overall good quality of life despite prevalent health issues, as shown in Table 1.

The binary logistic regression analysis identified several key health conditions associated with the prolapse. Sleep apnea had a strong positive association with prolapse (OR: 18.3, 95% CI: 5.29–87.0, p < 0.001), indicating a much higher likelihood of the outcome. Conversely, postpartum complications showed a significant protective effect (OR: 0.01, 95% CI: 0.00–0.02, p < 0.001). Menopausal status demonstrated significant association with PFD, as menopausal women exhibited increased odds of developing prolapse (OR: 2.48; 95% CI: 1.58-3.93; p < 0.001). Obesity was inversely associated with the prolapse, suggesting a protective effect (OR: 0.3, 95% CI: 0.17–0.50, p < 0.001). Gynecological disorders increased the odds of prolapse (OR: 1.74, 95% CI: 1.02–2.97, p = 0.042). Additionally, having two or more vaginal births raised the risk (OR: 1.49, 95% CI: 1.04–2.13, p = 0.028), as shown in Table 2.

Physical Functioning had a high mean score of 67.36 (SD = 11.62), with 97.6% of participants scoring ≥50, indicating strong physical capability. Role Physical and Bodily Pain had similarly high percentages of participants scoring ≥50 (90.4% and 95.3%, respectively), reflecting minimal physical limitations or pain. Vitality, however, showed lower scores, with 27.8% scoring < 50, suggesting that a significant portion of participants experienced lower energy levels. Mental health challenges were also notable, as 15.7% scored < 50 in the Mental Health domain. The SPF-12 Total score reflected a generally high overall quality of life, with 100% of participants scoring ≥50, as shown in Table 3.

The comparison of various HRQoL domains across six health conditions (UI, FI, prolapse, pelvic pain, urinary tract infection, and obstetric history) revealed significant findings. For Physical Functioning, notable differences were observed for FI (p = 0.006), pelvic pain (p = 0.001), and obstetric history (p < 0.001). Similarly, Role Physical (RP) was significantly impacted by prolapse (p < 0.001), urinary tract infection (p < 0.001), and obstetric history (p < 0.001). Additionally, Bodily Pain showed significant variations for prolapse (p < 0.001) and urinary tract infection (p < 0.001), while General Health (GH) was significantly different for FI (p = 0.011), prolapse (p = 0.032), pelvic pain (p < 0.001), and urinary tract infections (p = 0.006), as shown in Table 4.

The PFDI−20 scores demonstrated significant symptom improvements between baseline and 12–month follow–up assessments. The POPDI−6 measure decreased from baseline (mean: 45.3 ± 22.1) to 12 months (mean: 43.2 ± 21.8), with a mean difference (MD) of −2.10 (95% CI: −5.93 to 1.72, p = 0.01), indicating a reduction in symptoms. Similarly, the CRADI−8 scores improved from baseline (mean: 34.6 ± 19.2) to 12 months (mean: 32.4 ± 18.6), with an MD of −2.19 (95% CI: −5.15 to 0.78, p = 0.02). The total PFDI−20 score also showed significant improvement, decreasing from baseline (mean: 89.4 ± 35.6) to 12 months (mean: 85.5 ± 34.8), with an MD of −3.89 (95% CI: −14.43 to 6.65, p = 0.03). However, no significant changes were observed in Physical Activity scores (baseline: 7.2 ± 2.8; 12 months: 7.4 ± 2.9; p = 0.116) or Sleep Quality measures (baseline: 6.8 ± 3.1; 12 months: 6.9 ± 3.0; p = 0.866) over the follow–up period. These findings are summarized in Table 5.

In the bivariable analysis, SF−12 Physical Functioning remained significant (MD: 0.15, 95% CI: 0.037 to 0.267, p = 0.009), and being in the industry sector had a negative association (MD: −4.01, 95% CI: −7.91 to −0.11, p = 0.043). Sleep Apnea (Yes) (MD: −7.45, 95% CI: −10.11 to −4.80, p < 0.001) and Postpartum complications (Yes) (MD: −11.58, 95% CI: −14.33 to −8.83, p < 0.001) were strongly associated with the outcome, and Pelvic pain (Yes) was positively associated (MD: 2.85, 95% CI: 0.08 to 5.63, p = 0.044). However, In the multivariable analysis, SF−12 Physical Functioning remained significant (MD: 0.16, 95% CI: 0.031 to 0.281, p = 0.015), and the negative association with Industry employment persisted (MD: −5.58, 95% CI: −10.32 to −0.85, p = 0.021). Strong positive associations were observed for Sexual Dysfunction (Yes) (MD: 15.74, 95% CI: 9.45 to 22.03, p < 0.001), Sleep Apnea (Yes) (MD: −14.80, 95% CI: −21.50 to −8.11, p < 0.001), and Postpartum complications (Yes) (MD: −11.70, 95% CI: −16.62 to −6.77, p < 0.001). Menopause (Yes) was positively linked to the outcome (MD: 4.92, 95% CI: 0.90 to 8.93, p = 0.017), and Prolapse (Yes) (MD: −4.90, 95% CI: −7.88 to −1.93, p = 0.001) and Pelvic Pain (Yes) (MD: 3.93, 95% CI: 0.99 to 6.88, p = 0.009) remained significant, as shown in Table 6.

Correlation analysis demonstrated significant relationships between HRQoL domains and clinical variables. Age and BMI exhibited weak positive correlations with PFDI-20 subscales (POPDI-6, CRADI-8, UDI-6), indicating POP and urinary distress associations. SF-12 Physical Functioning showed strong positive correlations with Role Physical, Bodily Pain, and Mental Health components. Physical Component Summary (PCS) correlated strongly with Physical Functioning, while Mental Component Summary (MCS) demonstrated strong associations with Mental Health. PFD measures showed weaker correlations with HRQoL domains, as shown in Figure 1.

Figure 1

4 Discussion

This study provides a comprehensive analysis of the HRQoL and associated health conditions among a cohort of 1,651 women, highlighting several key findings that contribute to our understanding of PFD and its broader implications on wellbeing. The analysis of variables such as sleep apnea, postpartum complications, menopause, and obesity offers both positive and negative insights when compared to existing literature. The study reveals a high prevalence of sexual dysfunction (47%), sleep apnea (54%), and postpartum complications (65%) among the participants. These findings are consistent with previous literature, which has reported similar prevalence rates for these conditions (29, 30). For instance, a study reported that a prevalence of sexual dysfunction in 40% of women in the United States (29). Similarly, a study found that 48.3% of older adults experienced sexual dysfunction (31).

Previous research has consistently highlighted the substantial burden that pelvic floor disorders impose on women's physical and mental wellbeing. For instance studies demonstrated that POP significantly impairs physical functioning and daily activities, with a profound effect on women's self-reported quality of life (32–34). Similarly, a study reported that menopause exacerbates symptoms of PFD, leading to a decline in both physical and emotional health (35). Our findings support these conclusions by demonstrating strong associations between menopause, prolapse, and reduced HRQoL, especially in physical domains like role physical and bodily pain.

Sleep apnea and its role in PFD, while less frequently discussed, is gaining attention. Recent studies showed that women with sleep apnea tend to have worse outcomes in terms of UI and POP, which is reflected in our findings of a strong positive association between sleep apnea and lower quality of life (36, 37). The connection between sleep-disordered breathing and pelvic floor health may be mediated by several factors, including increased intra-abdominal pressure during sleep, which contributes to the worsening of pelvic floor symptoms (38–40). This is an area where further research is needed, as the interplay between sleep health and PFD remains understudied.

Interestingly, obesity has been traditionally considered a risk factor for PFD, particularly UI and POP (41). Recent studies consistently demonstrate that higher BMI is linked to greater severity of symptoms due to increased abdominal pressure and stress on pelvic tissues (42, 43). However, our study's finding of a protective effect of obesity on PFD contradicts the prevailing consensus. This discrepancy could be due to differences in population characteristics, such as access to healthcare, lifestyle interventions targeting obesity, or varying obesity phenotypes (e.g., distribution of fat mass) (44, 45). It is also possible that the protective effect observed is confounded by other variables, and further research is needed to clarify the relationship between BMI and pelvic health outcomes (46–48).

Postpartum complications are frequently cited as major contributors to long-term PFD (49). Bozkurt et al. (50) emphasizes the link between vaginal deliveries, particularly those involving instrumental assistance, and the development of conditions like UI and prolapse. In addition, further studies suggest that damage to the pelvic muscles and nerves during childbirth can have lasting effects, which contrasts with our finding that postpartum complications had a protective effect (51, 52). This could be explained by differences in the types of postpartum complications considered or by the influence of postnatal care practices, which have improved in recent years (53). However, the discrepancy highlights the need for a nuanced understanding of postpartum recovery and its long-term implications on pelvic health (54, 68).

Sexual dysfunction is a critical concern in women with pelvic floor disorders, as conditions like prolapse, incontinence, and CPP significantly impact sexual satisfaction and functioning (55, 56). Our results also suggest that sexual dysfunction is strongly associated with lower HRQoL, particularly in mental and emotional health domains. This finding reinforces the importance of addressing sexual health in the management of pelvic floor disorders, as it remains an underexplored yet significant factor affecting overall wellbeing.

The findings from your study reveal a significant prevalence of PFD symptoms among women, including UI (56%), pelvic organ prolapse (52%), and CPP (36%). These results are consistent with the literature, which indicates that PFDs are common and debilitating conditions affecting a substantial portion of the female population. For instance, a study reported that stress UI affects approximately 46% of women, while the lifetime risk of pelvic organ prolapse surgery is estimated to be between 12% and 19% (57–59). Additionally, the association of obesity with PFDs is well-documented; your study found that 49% of participants were classified as obese, aligning with findings of previous study (19), which emphasize obesity as a significant risk factor for developing UI and pelvic organ prolapse. Menopausal status also emerged as a critical factor in your results, with menopausal women exhibiting increased odds of prolapse (OR: 2.48), corroborating a study (60), who noted that hormonal changes during menopause significantly heighten the risk of female sexual dysfunction and other PFDs. Furthermore, your study's observation that 80% of participants had two or more vaginal births aligns with the literature, which highlights the increased risk of PFDs associated with multiple vaginal deliveries (59, 61–63).

PFDs represent a significant public health issue, imposing a considerable economic burden due to increased healthcare utilization, direct medical costs, and lost productivity. The prevalence of these disorders is notable, with estimates suggesting that they affect ~25% to 50% of women globally, leading to substantial healthcare demands and economic implications (25, 64, 69). Untreated PFDs often result in repeated medical consultations and a heightened risk of surgical interventions, which further exacerbates healthcare costs and resource utilization (62, 63, 70). The emotional and psychological impacts of PFDs also contribute to indirect costs, including reduced work capacity and caregiver burden, highlighting the multifaceted nature of the economic burden associated with these conditions (58).

Public health policies should prioritize subsidized screening programs and early diagnostic efforts to mitigate the long-term impacts of PFDs. Evidence suggests that timely interventions can significantly improve women's quality of life and enhance workforce participation, ultimately leading to reduced overall healthcare costs (65). Targeted measures, such as community outreach and improved access to care, are particularly critical in underserved regions where healthcare disparities may exacerbate the prevalence and consequences of untreated PFDs (66). The need for effective public health strategies is underscored by the projected increase in the prevalence of PFDs, which is expected to double from 2010 to 2050 in the United States alone, necessitating proactive measures to address this growing public health concern (67, 71).

This comprehensive cohort study elucidates the public health implications of untreated PFD through systematic evaluation of sociodemographic, lifestyle, and clinical determinants affecting symptom severity and HRQoL. Analysis revealed significant associations between PFD and comorbid conditions (sleep apnea, menopause, postpartum complications), emphasizing the necessity for early intervention strategies. These findings advance current understanding of PFD progression in an understudied population, providing evidence-based data to inform clinical protocols and public health initiatives.

Study limitations include its observational design, precluding causal relationship establishment between PFD and health outcomes, and potential reporting bias from self-reported variables (physical activity, sleep quality, PFD symptoms). Despite recruitment efforts, the cohort may not fully represent all untreated PFD populations across socioeconomic and geographic strata. Exclusion criteria (recent pregnancies, active PFD treatment) and 12-month follow-up duration limit result generalizability and long-term complication assessment. Randomized controlled trials with extended follow-up periods are needed to comprehensively evaluate PFD progression and public health impact.

5 Conclusion

In conclusion, this single-center cohort study demonstrates the significant impact of untreated PFD on women's health, particularly in terms of reduced HRQoL. Key factors such as sleep apnea, menopause, and postpartum complications were associated with increased symptom severity, while obesity showed a protective effect that warrants further investigation. Conditions like FI, pelvic pain, and prolapse were linked to poorer physical functioning and heightened bodily pain. Despite the prevalence of PFD, many participants maintained good overall health, indicating that early diagnosis and intervention could mitigate long-term consequences. These findings highlight the need for targeted public health strategies, improved screening, and timely treatment to reduce the burden of untreated PFD and improve women's quality of life.

References

• 1.

  TimSMazur-BialyAI. The most common functional disorders and factors affecting female pelvic floor. Life. (2021) 11:1397. 10.3390/life11121397

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 2.

  DavisKKumarDStantonSL. Pelvic floor dysfunction: the need for a multidisciplinary team approach. Urogynecology. (2003) 9:23–36. 10.1097/01.SPV.0000056863.70573.B0

  • CrossRef
  • Google Scholar

• 3.

  ZhoolidehPGhaderiFSalahzadehZ. Are there any relations between posture and pelvic floor disorders? a literature review. Cresc J Med Biol Sci. (2017) 4:4.

  • Google Scholar

• 4.

  La RosaVCiebieraMLinL-TSleimanZCerentiniTLordeloPet al. Multidisciplinary management of women with pelvic organ prolapse, urinary incontinence and lower urinary tract symptoms. A clinical and psychological overview. Menopause Review/Przeglad Menopauzalny. (2019) 18:184–90. 10.5114/pm.2019.89496

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 5.

  American College of Obstetricians and Gynecologists and the American Urogynecologic Society. Pelvic organ prolapse. Female Pelvic Med Reconstr Surg. (2019) 25(6):397-408. 10.1097/SPV.0000000000000794

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 6.

  GeJYangPZhangYLiXWangQLuY. Prevalence and risk factors of urinary incontinence in Chinese women: a population-based study. Asia Pacific J Public Health. (2015) 27:NP1118–NP31. 10.1177/1010539511429370

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 7.

  AlpermannBZhanS. Population planning after the one-child policy: Shifting modes of political steering in China. J Contemp China. (2019) 28:348–66. 10.1080/10670564.2018.1542218

  • CrossRef
  • Google Scholar

• 8.

  AbrahamsonP. End of an era? China's one-child policy and its unintended consequences. Asian Soc Work Policy Rev. (2016) 10:326–38. 10.1111/aswp.12101

  • CrossRef
  • Google Scholar

• 9.

  WangBChenYZhuXWangTLiMHuangYet al. Global burden and trends of pelvic organ prolapse associated with aging women: an observational trend study from 1990 to 2019. Front Public Health. (2022) 10:975829. 10.3389/fpubh.2022.975829

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 10.

  NauheimJMcKayELaudanoMAbrahamN. Healthcare disparities in the treatment of pelvic floor disorders. Curr Bladder Dysfunct Rep. (2020) 15:135–41. 10.1007/s11884-020-00598-w

  • CrossRef
  • Google Scholar

• 11.

  WynadenDChapmanROrbAMcGowanSZeemanZYeakS. Factors that influence Asian communities' access to mental health care. Int J Ment Health Nurs. (2005) 14:88–95. 10.1111/j.1440-0979.2005.00364.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 12.

  LaiY-tLinA-wZhengZ-hWangY-lYuH-hJiangX-yet al. Perceptions of pelvic floor dysfunction and rehabilitation care amongst women in southeast China after radical hysterectomy: a qualitative study. BMC Women's Health. (2022) 22:108. 10.1186/s12905-022-01687-0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 13.

  Dominiak-FeldenGCohetCAtrux-TallauSGiletHTristramAFianderA. Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK. BMC Public Health. (2013) 13:1–11. 10.1186/1471-2458-13-1065

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 14.

  Martínez-GalianoJMPeinado-MolinaRAMartínez-VazquezSHita-ContrerasFDelgado-RodríguezMHernández-MartínezA. Influence of pelvic floor disorders on sexuality in women. Int J Gyneco Obstet. (2024) 164:1141–50. 10.1002/ijgo.15189

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 15.

  HallockJLHandaVL. The epidemiology of pelvic floor disorders and childbirth: an update. Obstet Gynecol Clinics. (2016) 43:1–13. 10.1016/j.ogc.2015.10.008

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 16.

  ZhuQShuHDaiZ. Effect of pelvic floor dysfunction on sexual function and quality of life in Chinese women of different ages: an observational study. Geriatr Gerontol Int. (2019) 19:299–304. 10.1111/ggi.13618

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 17.

  XueKPalmerMHZhouF. Prevalence and associated factors of urinary incontinence in women living in China: a literature review. BMC Urol. (2020) 20:1–26. 10.1186/s12894-020-00735-x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 18.

  De PutterCSellesRPolinderSPannemanMHoviusSvan BeeckEF. Economic impact of hand and wrist injuries: health-care costs and productivity costs in a population-based study. JBJS. (2012) 94:e56. 10.2106/JBJS.K.00561

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 19.

  Peinado-MolinaRAHernández-MartínezAMartínez-VázquezSRodríguez-AlmagroJMartínez-GalianoJM. Pelvic floor dysfunction: prevalence and associated factors. BMC Public Health. (2023) 23:2005. 10.1186/s12889-023-16901-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 20.

  HutchisonDAliMZilliouxJOrtizNMSmithRRappDE. Pelvic floor muscle training in the management of female pelvic floor disorders. Curr Bladder Dysfunct Rep. (2022) 17:115–24. 10.1007/s11884-022-00653-8

  • CrossRef
  • Google Scholar

• 21.

  AschkenaziSOGoldbergRP. Female sexual function and the pelvic floor. Expert Rev Obstet Gynecol. (2009) 4:165–78. 10.1586/17474108.4.2.165

  • CrossRef
  • Google Scholar

• 22.

  WuXYiXZhengXChenZLiuJDaiX. Knowledge, attitudes, and practice of pelvic floor dysfunction and pelvic floor ultrasound among women of childbearing age in Sichuan, China. Front Public Health. (2023) 11:1160733. 10.3389/fpubh.2023.1160733

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 23.

  DavisKKumarD. Pelvic floor dysfunction: a conceptual framework for collaborative patient-centred care. J Adv Nurs. (2003) 43:555–68. 10.1046/j.1365-2648.2003.02754.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 24.

  ElneilSRomanziLGohJHaylenBGrace ChenCCGhoniemGet al. An International Continence Society (ICS) report on the terminology for female pelvic floor fistulas. Neurourol Urodyn. (2020) 39:2040–71. 10.1002/nau.24508

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 25.

  WuJMVaughanCPGoodePSReddenDTBurgioKLRichterHEet al. Prevalence and trends of symptomatic pelvic floor disorders in US women. Obstet Gynecol. (2014) 123:141–8. 10.1097/AOG.0000000000000057

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 26.

  ShahCHBrownJD. Reliability and validity of the short-form 12 item version 2 (SF– 12v2) health-related quality of life survey and disutilities associated with relevant conditions in the US older adult population. J Clin Med. (2020) 9:661. 10.3390/jcm9030661

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 27.

  de ArrudaGTdos Santos HenriqueTVirtuosoJF. Pelvic floor distress inventory (PFDI)—systematic review of measurement properties. Int Urogynecol J. (2021) 32:2657–69. 10.1007/s00192-021-04748-4

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 28.

  RanitiMBWaloszekJMSchwartzOAllenNBTrinderJ. Factor structure and psychometric properties of the Pittsburgh Sleep Quality Index in community-based adolescents. Sleep. (2018) 41:zsy066. 10.1093/sleep/zsy066

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 29.

  Martínez VázquezSHernández MartínezAPeinado MolinaRAMartínez GalianoJM. Association between sexual function in women and sleep quality. Front Med. (2023) 10:1196540. 10.3389/fmed.2023.1196540

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 30.

  ShahAFChawlaIGoelKGollenRSinghR. Impact of obesity on female sexual dysfunction: a remiss. Curr Women's Health Rev. (2021) 17:21–8. 10.2174/1573404816999200917121519

  • CrossRef
  • Google Scholar

• 31.

  TinettiAWeirNTangyotkajohnUJacquesAThompsonJBriffaK. Help-seeking behaviour for pelvic floor dysfunction in women over 55: drivers and barriers. Int Urogynecol J. (2018) 29:1645–53. 10.1007/s00192-018-3618-2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 32.

  BlomquistJLCarrollMMuñozAHandaVL. Pelvic floor muscle strength and the incidence of pelvic floor disorders after vaginal and cesarean delivery. Am J Obstet Gynecol. (2020) 222:e1–e8. 10.1016/j.ajog.2019.08.003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 33.

  OuchiMKatoKGotohMSuzukiS. Physical activity and pelvic floor muscle training in patients with pelvic organ prolapse: a pilot study. Int Urogynecol J. (2017) 28:1807–15. 10.1007/s00192-017-3356-x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 34.

  ImotoASarkerMAkterRMatsuyamaAHondaS. Health-related quality of life in parous women with pelvic organ prolapse and/or urinary incontinence in Bangladesh. Int Urogynecol J. (2021) 32:887–95. 10.1007/s00192-020-04410-5

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 35.

  Carcelén-FraileMdCAibar-AlmazánAMartínez-AmatACruz-DíazDDíaz-MohedoERedecillas-PeiróMTet al. Effects of physical exercise on sexual function and quality of sexual life related to menopausal symptoms in peri-and postmenopausal women: A systematic review. Int J Environm Res Public Health. (2020) 17:2680. 10.3390/ijerph17082680

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 36.

  FitzgeraldMPMulliganMParthasarathyS. Paper 47: association of obstructive sleep apnea and nocturia, and improvement of nocturia with continuous positive airways (CPAP) treatment of OSA. Urogynecology. (2005) 11:S23. 10.1097/01.spv.0000176125.94409.8b

  • CrossRef
  • Google Scholar

• 37.

  CameronAPSmithARLaiHHBradleyCSLiuABMerionRMet al. Bowel function, sexual function, and symptoms of pelvic organ prolapse in women with and without urinary incontinence. Neurourol Urodyn. (2018) 37:2586–96. 10.1002/nau.23587

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 38.

  TanI-FHorneAW. Obesity and chronic pelvic pain. In: Obesity Gynecology.London: Elsevier (2020). p. 281–91.

  • Google Scholar

• 39.

  BharuchaAE. Pelvic floor: anatomy and function. Neurogastroenterol Motility. (2006) 18:507–19. 10.1111/j.1365-2982.2006.00803.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 40.

  MemonHUHandaVL. Vaginal childbirth and pelvic floor disorders. Women's Health. (2013) 9:265–77. 10.2217/WHE.13.17

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 41.

  GreerWJRichterHEBartolucciAABurgioKL. Obesity and pelvic floor disorders: a systematic review. Obstet Gynecol. (2008) 112:341–9. 10.1097/AOG.0b013e31817cfdde

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 42.

  ChilakaCToozs-HobsonPChilakaV. Pelvic floor dysfunction and obesity. Best Pract Res Clin Obstet Gynaecol. 90:102389. 10.1016/j.bpobgyn.2023.102389

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 43.

  LavenBAOrsiniNAnderssonS-OJohanssonJ-EGerberGSWolkA. Birth weight, abdominal obesity and the risk of lower urinary tract symptoms in a population based study of Swedish men. J Urol. (2008) 179:1891–6. 10.1016/j.juro.2008.01.029

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 44.

  PrattCALoriaCMArteagaSSNicastroHLLopez-ClassMde JesusJMet al. A systematic review of obesity disparities research. Am J Prev Med. (2017) 53:113–22. 10.1016/j.amepre.2017.01.041

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 45.

  BansalVConroyCLeeJSchwartzATominagaGCoimbraR. Is bigger better? The effect of obesity on pelvic fractures after side impact motor vehicle crashes. J Trauma Acute Care Surg. (2009) 67:709–14. 10.1097/TA.0b013e3181af6cc1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 46.

  GoldbergRPKwonCGandhiSAtkuruLVSorensenMSandPK. Urinary incontinence among mothers of multiples: the protective effect of cesarean delivery. Am J Obstet Gynecol. (2003) 188:1447–53. 10.1067/mob.2003.451

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 47.

  SchultenSFClaas-QuaxMJWeemhoffMvan EijndhovenHWvan LeijsenSAVergeldtTFet al. Risk factors for primary pelvic organ prolapse and prolapse recurrence: an updated systematic review and meta-analysis. Am J Obstet Gynecol. (2022) 227:192–208. 10.1016/j.ajog.2022.04.046

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 48.

  BurnsJWQuartanaPJBruehlSJanssenIDuganSAAppelhansBet al. Chronic pain, body mass index and cardiovascular disease risk factors: tests of moderation, unique and shared relationships in the Study of Women's Health Across the Nation (SWAN). J Behav Med. (2015) 38:372–83. 10.1007/s10865-014-9608-z

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 49.

  DasikanZOzturkROzturkA. Pelvic floor dysfunction symptoms and risk factors at the first year of postpartum women: a cross-sectional study. Contemp Nurse. (2020) 56:132–45. 10.1080/10376178.2020.1749099

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 50.

  BozkurtMYumruAESahinL. Pelvic floor dysfunction, and effects of pregnancy and mode of delivery on pelvic floor. Taiwanese J Obstet Gynecol. (2014) 53:452–8. 10.1016/j.tjog.2014.08.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 51.

  BaesslerKSchuesslerB. Childbirth-induced trauma to the urethral continence mechanism: review and recommendations. Urology. (2003) 62:39–44. 10.1016/j.urology.2003.08.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 52.

  PhillipsCMongaA. Childbirth and the pelvic floor: “the gynaecological consequences”. Rev Gynaecolog Pract. (2005) 5:15–22. 10.1016/j.rigp.2004.09.002

  • CrossRef
  • Google Scholar

• 53.

  DietzHSchierlitzL. Pelvic floor trauma in childbirth–myth or reality?Austral New Zeal J Obstet Gynaecol. (2005) 45:3–11. 10.1111/j.1479-828X.2005.00363.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 54.

  O'MalleyDHigginsASmithV. Exploring the complexities of postpartum sexual health. Current Sexual Health Rep. (2021) 2021:1–8. 10.1007/s11930-021-00315-6

  • CrossRef
  • Google Scholar

• 55.

  VerbeekMHaywardL. Pelvic floor dysfunction and its effect on quality of sexual life. Sexual Med Rev. (2019) 7:559–64. 10.1016/j.sxmr.2019.05.007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 56.

  AchtariCDwyerPL. Sexual function and pelvic floor disorders. Best Pract Res Clini Obstet Gynaecol. (2005) 19:993–1008. 10.1016/j.bpobgyn.2005.08.012

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 57.

  ZhangS. The causal effect of reproductive factors on pelvic floor dysfunction: a mendelian randomization study. BMC Women S Health. (2024) 24:1. 10.1186/s12905-024-02914-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 58.

  GhettiCSkoczylasLCOliphantSSNikolajskiCLowderJL. The emotional burden of pelvic organ prolapse in women seeking treatment. Female Pelvic Med Reconst Surg. (2015) 21:332–8. 10.1097/SPV.0000000000000190

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 59.

  LaakkonenEKKulmalaJAukeePHakonenHKujalaUMLoweDAet al. Female reproductive factors are associated with objectively measured physical activity in middle-aged women. PLoS ONE. (2017) 12:e0172054. 10.1371/journal.pone.0172054

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 60.

  ZhuoZWangCYuHLiJ. The relationship between pelvic floor function and sexual function in perimenopausal women. Sexual Med. (2021) 9:100441. 10.1016/j.esxm.2021.100441

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 61.

  Hage-FransenMAHWiezerMOttoADWieffer-PlatvoetMSlotmanMHMariaWGN-vdSet al. Pregnancy- and obstetric-related risk factors for urinary incontinence, fecal incontinence, or pelvic organ prolapse later in life: a systematic review and meta-analysis. Acta Obstetricia Et Gynecologica Scandinavica. (2020) 100:373–82. 10.1111/aogs.14027

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 62.

  DemissieBA. Prevalence and associated factors of symptomatic pelvic floor disorders among women living in Debre Tabor Town, Northwest Amhara, Ethiopia. BMC Women S Health. (2024) 24:367. 10.1186/s12905-024-03176-y

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 63.

  MolinaRAP. Influence of pelvic floor disorders on quality of life in women. Front Public Health. (2023) 11:1180907. 10.3389/fpubh.2023.1180907

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 64.

  DuranPSesilloFBCookMSBurnettLAMenefeeSADoEet al. Proregenerative extracellular matrix hydrogel mitigates pathological alterations of pelvic skeletal muscles after birth injury. Science Transl Med. (2023) 15:abj3138. 10.1126/scitranslmed.abj3138

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 65.

  DheresaMWorkuAOljiraLMengisteBAssefaNBerhaneY. One in five women suffer from pelvic floor disorders in Kersa district Eastern Ethiopia: a community-based study. BMC Women S Health. (2018) 18:1. 10.1186/s12905-018-0585-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 66.

  HasudaTUedaAWeiCN. Prevalence of symptomatic pelvic floor disorders among Japanese women. J Women S Health Care. (2017) 06:1000389. 10.4172/2167-0420.1000389

  • CrossRef
  • Google Scholar

• 67.

  ReinerCSWilliamsonTWinklehnerTLisseSFinkDDeLanceyJOet al. The 3D pelvic inclination correction system (PICS): a universally applicable coordinate system for isovolumetric imaging measurements, tested in women with pelvic organ prolapse (POP). Comput Med Imag Graph. (2017) 59:28–37. 10.1016/j.compmedimag.2017.05.005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 68.

  AwanUAGuoXKhattakAAHassanUBashirS. HPV vaccination and cervical cancer screening in Afghanistan threatened. Lancet Infect Dis. (2023) 23:141–2. 10.1016/S1473-3099(22)00868-4

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 69.

  ShoukatTAwanUAMahmoodTAfzalMSWasifSAhmedHet al. Epidemiology of toxoplasmosis among the Pakistani population: a systematic review and meta-analysis. Pathogens. (2022) 11:675. 10.3390/pathogens11060675

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 70.

  BashirSHussainMAli KhanAHassanUMushtaqKSHameedMet al. Renal transplant pathology: demographic features and histopathological analysis of the causes of graft dysfunction. Int J Nephrol. (2020) 2020:7289701. 10.1155/2020/7289701

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 71.

  KhattakAAAwanUANadeemMFYaqoobAAfzalMS. Chloroquine-resistant Plasmodium falciparum in Pakistan. Lancet Infect Dis. (2021) 21:1632. 10.1016/S1473-3099(21)00700-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar